Market Closed -
Nasdaq
04:00:00 2024-06-07 pm EDT
|
5-day change
|
1st Jan Change
|
2.78
USD
|
-5.12%
|
|
+14.40%
|
-25.67%
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Capitalization
1 |
2,008
|
981.7
|
738.5
|
155
|
899.3
|
668.3
|
-
|
-
|
Enterprise Value (EV)
1 |
5,472
|
4,406
|
738.5
|
155
|
899.3
|
668.3
|
668.3
|
668.3
|
P/E ratio
|
-22.8
x
|
-6.98
x
|
4.23
x
|
-9.24
x
|
-3.04
x
|
-2.44
x
|
-3.71
x
|
-
|
Yield
|
7.11%
|
4.37%
|
1.29%
|
6.18%
|
1.07%
|
1.44%
|
2.52%
|
7.19%
|
Capitalization / Revenue
|
1.93
x
|
0.6
x
|
0.53
x
|
0.12
x
|
0.64
x
|
0.44
x
|
0.41
x
|
0.39
x
|
EV / Revenue
|
1.93
x
|
0.6
x
|
0.53
x
|
0.12
x
|
0.64
x
|
0.44
x
|
0.41
x
|
0.39
x
|
EV / EBITDA
|
3.73
x
|
0.74
x
|
2.87
x
|
1.05
x
|
3.7
x
|
2.31
x
|
2.07
x
|
1.71
x
|
EV / FCF
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Yield
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Price to Book
|
0.73
x
|
0.39
x
|
-
|
-
|
-
|
-
|
-
|
-
|
Nbr of stocks (in thousands)
|
237,899
|
238,268
|
238,995
|
239,704
|
240,450
|
240,394
|
-
|
-
|
Reference price
2 |
8.440
|
4.120
|
3.090
|
0.6468
|
3.740
|
2.780
|
2.780
|
2.780
|
Announcement Date
|
3/2/20
|
2/24/21
|
2/23/22
|
3/1/23
|
2/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net sales
1 |
1,040
|
1,632
|
1,383
|
1,284
|
1,410
|
1,516
|
1,649
|
1,718
|
EBITDA
1 |
538
|
1,331
|
257.3
|
148.1
|
242.8
|
288.7
|
323.3
|
390.3
|
EBIT
1 |
96.73
|
94.93
|
-31.15
|
-93.82
|
-103.3
|
-28.39
|
49.46
|
91.12
|
Operating Margin
|
9.3%
|
5.82%
|
-2.25%
|
-7.31%
|
-7.32%
|
-1.87%
|
3%
|
5.3%
|
Earnings before Tax (EBT)
1 |
-82.84
|
-133.1
|
181.4
|
-21.12
|
-272.7
|
-280.7
|
-176.4
|
-92.73
|
Net income
1 |
-88.23
|
-139.5
|
174.5
|
-15.77
|
-293.6
|
-259.8
|
-210.4
|
-84.84
|
Net margin
|
-8.48%
|
-8.54%
|
12.62%
|
-1.23%
|
-20.82%
|
-17.14%
|
-12.76%
|
-4.94%
|
EPS
2 |
-0.3700
|
-0.5900
|
0.7300
|
-0.0700
|
-1.230
|
-1.140
|
-0.7500
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF margin
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (EBITDA)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
FCF Conversion (Net income)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Dividend per Share
2 |
0.6000
|
0.1800
|
0.0400
|
0.0400
|
0.0400
|
0.0400
|
0.0700
|
0.2000
|
Announcement Date
|
3/2/20
|
2/24/21
|
2/23/22
|
3/1/23
|
2/26/24
|
-
|
-
|
-
|
Fiscal Period: December |
2021 Q4
|
2022 Q1
|
2022 Q2
|
2022 Q3
|
2022 Q4
|
2023 Q1
|
2023 Q2
|
2023 Q3
|
2023 Q4
|
2024 Q1
|
2024 Q2
|
2024 Q3
|
2024 Q4
|
2025 Q1
|
2025 Q2
|
---|
Net sales
1 |
336.7
|
310.7
|
313
|
322.9
|
336.9
|
346
|
346.2
|
356.5
|
361.5
|
370.8
|
372.1
|
383.3
|
390
|
405.1
|
407.7
|
EBITDA
1 |
54.47
|
33.78
|
47.98
|
35.78
|
45.96
|
53.98
|
62.14
|
58.81
|
59.19
|
64.06
|
68.29
|
73.94
|
82.46
|
77.45
|
78.35
|
EBIT
1 |
-16.25
|
-23.48
|
-19.12
|
-33.05
|
-18.18
|
-16.74
|
-33.03
|
-20.93
|
-32.59
|
-26.76
|
-8.293
|
-1.65
|
8.312
|
-
|
-
|
Operating Margin
|
-4.83%
|
-7.56%
|
-6.11%
|
-10.24%
|
-5.4%
|
-4.84%
|
-9.54%
|
-5.87%
|
-9.01%
|
-7.22%
|
-2.23%
|
-0.43%
|
2.13%
|
-
|
-
|
Earnings before Tax (EBT)
1 |
367.2
|
-89.25
|
-113.2
|
-83.61
|
-62.83
|
-53.28
|
-75.28
|
-65.44
|
-79.9
|
-87.97
|
-66.47
|
-59.56
|
-52.79
|
-51.38
|
-50.22
|
Net income
1 |
365.6
|
240.4
|
-109.4
|
-81.49
|
-65.32
|
-52.66
|
-72.57
|
-65.78
|
-102.6
|
-86.26
|
-64.82
|
-57.81
|
-50.95
|
-62.24
|
-61.7
|
Net margin
|
108.57%
|
77.37%
|
-34.94%
|
-25.24%
|
-19.39%
|
-15.22%
|
-20.96%
|
-18.45%
|
-28.37%
|
-23.26%
|
-17.42%
|
-15.08%
|
-13.06%
|
-15.36%
|
-15.14%
|
EPS
2 |
1.540
|
1.010
|
-0.4600
|
-0.3400
|
-0.2700
|
-0.2200
|
-0.3000
|
-0.2800
|
-0.4300
|
-0.3600
|
-0.2800
|
-0.2600
|
-0.2400
|
-0.2100
|
-0.2000
|
Dividend per Share
2 |
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
-
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
0.0100
|
Announcement Date
|
2/23/22
|
5/3/22
|
8/3/22
|
11/2/22
|
3/1/23
|
5/8/23
|
8/1/23
|
11/1/23
|
2/26/24
|
5/6/24
|
-
|
-
|
-
|
-
|
-
|
Fiscal Period: December |
2019
|
2020
|
2021
|
2022
|
2023
|
2024
|
2025
|
2026
|
---|
Net Debt
|
3,464
|
3,424
|
-
|
-
|
-
|
-
|
-
|
-
|
Net Cash position
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Leverage (Debt/EBITDA)
|
6.439
x
|
2.572
x
|
-
|
-
|
-
|
-
|
-
|
-
|
Free Cash Flow
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
ROE (net income / shareholders' equity)
|
1.45%
|
-5.33%
|
-
|
-
|
-
|
-
|
-
|
-
|
ROA (Net income/ Total Assets)
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Assets
1 |
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Book Value Per Share
|
11.50
|
10.50
|
-
|
-
|
-
|
-
|
-
|
-
|
Cash Flow per Share
|
1.120
|
0.6700
|
-0.2700
|
-0.1700
|
-
|
-
|
-
|
-
|
Capex
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Capex / Sales
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
-
|
Announcement Date
|
3/2/20
|
2/24/21
|
2/23/22
|
3/1/23
|
2/26/24
|
-
|
-
|
-
|
Last Close Price
2.78
USD Average target price
3.5
USD Spread / Average Target +25.90% Consensus |
1st Jan change
|
Capi.
|
---|
| -25.67% | 668M | | +15.13% | 62.07B | | -0.26% | 20.09B | | -2.58% | 13.58B | | +4.83% | 7.94B | | -4.12% | 6.28B | | -1.96% | 3.24B | | +9.37% | 3.22B | | -8.88% | 2.98B | | +17.44% | 2.85B |
Healthcare REITs
|